A potential role for B cells in suppressed immune responses in cord blood transplant recipients

Bone Marrow Transplantation

Volumn 48, Issue 1, 2013, Pages 85-93

  Beaudette Zlatanova, B C ^a   Le, P T ^a   Knight, K L ^a   Zhang, S ^a   Zakrzewski, S ^a   Parthasarathy, M ^a   Stiff, P J ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Cord blood; Hematopoietic SCT; Immune reconstitution; Spectratype analysis

Indexed keywords

INTERLEUKIN 10;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ARTICLE; B LYMPHOCYTE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE SEVERITY; FEMALE; GENETIC VARIABILITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IATROGENIC DISEASE; IMMUNE DEFICIENCY; INCIDENCE; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; ANTIGENS, CD5; B-LYMPHOCYTES; COMPLEMENTARITY DETERMINING REGIONS; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; ILLINOIS; IMMUNOCOMPROMISED HOST; INCIDENCE; INTERLEUKIN-10; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, ANTIGEN, T-CELL; SIBLINGS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84872141803     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.104     Document Type: Article

References (42)

1. Hao QL, Shah AJ, Thiemann FT, Smogorzewska EM, Crooks GM. A functional comparison of CD34+CD38-cells in cord blood and bone marrow. Blood 1995; 86: 3745-3753.
2. Albano MS, Taylor P, Pass RF, Scaradavou A, Ciubotariu R, Carrier C et al. Umbilical cord blood transplantation and cytomegalovirus: Posttransplantation infection and donor screening. Blood 2006; 108: 4275-4282. (Pubitemid 44913304)
3. Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol 2010; 11: 653-660.
4. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265-2275. (Pubitemid 39552742)
5. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004; 351: 2276-2285. (Pubitemid 39552743)
6. Almyroudis NG, Fabian J, Hahn T, Segal BH, Wetzler M, McCarthy Jr PL. Late infectious complications after cord blood stem cell transplantation. Eur J Clin Microbiol Infect Dis 2009; 28: 1405-1408.
7. Ooi J, Iseki T, Takahashi S, Tomonari A, Nagayama H, Ishii K et al. A clinical comparison of unrelated cord blood transplantation and unrelated bone marrow transplantation for adult patients with acute leukaemia in complete remission. Br J Haematol 2002; 118: 140-143. (Pubitemid 34779528)
8. Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962-2971.
9. Rocha V, Gluckman E. Eurocord, European B, Marrow Transplant G. Clinical use of umbilical cord blood hematopoietic stem cells. Biol Blood Marrow Transplant 2006; 12(1 Suppl 1): 34-41. (Pubitemid 43034117)
10. Barker JN, Hough RE, van Burik JA, DeFor TE, MacMillan ML, O'Brien MR et al. Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source. Biol Blood Marrow Transplant 2005; 11: 362-370. (Pubitemid 40542929)
11. Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 2007; 369: 1947-1954. (Pubitemid 46874578)
12. Parody R, Martino R, Rovira M, Vazquez L, Vazquez MJ, de la Camara R et al. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Biol Blood Marrow Transplant 2006; 12: 734-748. (Pubitemid 43899409)
13. Hentschke P, Omazic B, Mattsson J, Nasman-Bjork I, Lundkvist I, Gigliotti D et al. T-cell receptor Vbeta repertoire after myeloablative and reduced intensity conditioning allogeneic haematopoietic stem cell transplantation. Scand J Immunol 2005; 61: 285-294. (Pubitemid 40462780)
14. Verfuerth S, Peggs K, Vyas P, Barnett L, O'Reilly RJ, Mackinnon S. Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-celldepleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusions on T-cell repertoire. Blood 2000; 95: 3990-3995. (Pubitemid 30412879)
15. Wu CJ, Chillemi A, Alyea EP, Orsini E, Neuberg D, Soiffer RJ et al. Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism. Blood 2000; 95: 352-359. (Pubitemid 30017264)
16. Klein AK, Patel DD, Gooding ME, Sempowski GD, Chen BJ, Liu C et al. T-Cell recovery in adults and children following umbilical cord blood transplantation. Biol Blood Marrow Transplant 2001; 7: 454-466. (Pubitemid 32952319)
17. Talvensaari K, Clave E, Douay C, Rabian C, Garderet L, Busson M et al. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 2002; 99: 1458-1464. (Pubitemid 34547105)
18. Hamza NS, Lisgaris M, Yadavalli G, Nadeau L, Fox R, Fu P et al. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol 2004; 124: 488-498. (Pubitemid 38230595)
19. Ottinger HD, Beelen DW, Scheulen B, Schaefer UW, Grosse-Wilde H. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 1996; 88: 2775-2779. (Pubitemid 26327533)
20. Petersen SL, Ryder LP, Bjork P, Madsen HO, Heilmann C, Jacobsen N et al. A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors. Bone Marrow Transplant 2003; 32: 65-72. (Pubitemid 36850282)
21. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008; 28: 639-650. (Pubitemid 351636247)
22. Yang M, Sun L, Wang S, Ko KH, Xu H, Zheng BJ et al. Novel function of B cellactivating factor in the induction of IL-10-producing regulatory B cells. J Immunol 2010; 184: 3321-3325.
23. Saavedra S, Sanz GF, Jarque I, Moscardo F, Jimenez C, Lorenzo I et al. Early infections in adult patients undergoing unrelated donor cord blood transplantation. Bone Marrow Transplant 2002; 30: 937-943. (Pubitemid 36097484)
24. Giraud P, Thuret I, Reviron D, Chambost H, Brunet C, Novakovitch G et al. Immune reconstitution and outcome after unrelated cord blood transplantation: a single paediatric institution experience. Bone Marrow Transplant 2000; 25: 53-57. (Pubitemid 30093156)
25. Komanduri St KV, John LS, de Lima M, McMannis J, Rosinski S, McNiece I et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood 2007; 110: 4543-4551. (Pubitemid 351377822)
26. Gokmen E, Raaphorst FM, Boldt DH, Teale JM. Ig heavy chain third complementarity determining regions (H CDR3s) after stem cell transplantation do not resemble the developing human fetal H CDR3s in size distribution and Ig gene utilization. Blood 1998; 92: 2802-2814. (Pubitemid 28469094)
27. Suzuki I, Milner EC, Glas AM, Hufnagle WO, Rao SP, Pfister L et al. Immunoglobulin heavy chain variable region gene usage in bone marrow transplant recipients: lack of somatic mutation indicates a maturational arrest. Blood 1996; 87: 1873-1880. (Pubitemid 26068903)
28. D'Sa S, Peggs K, Pizzey A, Verfuerth S, Thuraisundaram D, Watts M et al. T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor lymphocyte infusions. Br J Haematol 2003; 123: 309-322. (Pubitemid 37305067)
29. Omazic B, Hentschke P, Nasman-Bjork I, Mattsson J, Oxelius VA, Ringden O et al. Reconstitution of the Ig heavy chain CDR3 repertoire after allogeneic haematopoietic stem cell transplantation with myeloablative or reduced-intensity conditioning regimens. Scand J Immunol 2005; 61: 72-81. (Pubitemid 40188350)
30. Batten M, Groom J, Cachero TG, Qian F, Schneider P, Tschopp J et al. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 2000; 192: 1453-1466.
31. Rolink AG, Tschopp J, Schneider P, Melchers F. BAFF is a survival and maturation factor for mouse B cells. Eur J Immunol 2002; 32: 2004-2010. (Pubitemid 34814557)
32. Fu L, Lin-Lee YC, Pham LV, Tamayo A, Yoshimura L, Ford RJ. Constitutive NFkappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas. Blood 2006; 107: 4540-4548. (Pubitemid 43801383)
33. Novak AJ, Bram RJ, Kay NE, Jelinek DF. Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival. Blood 2002; 100: 2973-2979.
34. Jacobson CA, Turki AT, McDonough SM, Stevenson KE, Kim HT, Kao G et al. Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2012; 18: 565-574.
35. Abrahamsen IW, Somme S, Heldal D, Egeland T, Kvale D, Tjonnfjord GE. Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease. Haematologica 2005; 90: 86-93. (Pubitemid 40193758)
36. Sanchez-Garcia J, Serrano J, Gomez P, Martinez F, Martin C, Roman-Gomez J et al. The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia. Haematologica 2006; 91: 340-347.
37. Small TN, Keever CA, Weiner-Fedus S, Heller G, O'Reilly RJ, Flomenberg N. B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny. Blood 1990; 76: 1647-1656. (Pubitemid 20364032)
38. Villasenor-Bustamante S, Alvarado-De La BC, Richaud-Patin Y, Martinez-Ayala H, Llorente L. Possible role of interleukin-10 in autoantibody production and in the fate of human cord blood CD5+ B lymphocytes. Scand J Immunol 1999; 49: 629-632. (Pubitemid 29292524)
39. Marie-Cardine A, Divay F, Dutot I, Green A, Perdrix A, Boyer O et al. Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation. Clin Immunol 2008; 127: 14-25.
40. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002; 16: 219-230. (Pubitemid 34211962)
41. Bouaziz JD, Calbo S, Maho-Vaillant M, Saussine A, Bagot M, Bensussan A et al. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol 2010; 40: 2686-2691.
42. Tretter T, Venigalla RK, Eckstein V, Saffrich R, Sertel S, Ho AD et al. Induction of CD4+ T-cell anergy and apoptosis by activated human B cells. Blood 2008; 112: 4555-4564.